Insider Yu Alice Lin-Tsing Acquires Shares in OPK
Yu Alice Lin-Tsing purchased 30,000 shares of OPK on June 18, 2026.
Key Points
- Yu Alice Lin-Tsing bought 30,000 shares of OPK on June 18, 2026, as part of insider transactions.
- OPK shares traded near $1.43 on Tuesday, with significant institutional activity from BlackRock and Vanguard.
- Analysts from Barrington Research maintain a buy rating on OPK, with a price target of $1.50.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Yu Alice Lin-Tsing, an insider at OPK, purchased 30,000 shares of the company on June 18, 2026. This transaction wasn't part of a pre-planned trading program. Insider buying can sometimes indicate confidence in the company, though the exact price and value of the transaction weren't specified.
Other Institutional Activity in OPK
Institutional investors have been active in OPK. BlackRock, Inc. increased its holdings by 1,380,193 shares, bringing its total to 36,232,223 shares valued at approximately $41.3 million. Meanwhile, Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, acquiring 14,769,719 and 14,499,164 shares, respectively. Geode Capital Management, LLC also grew its stake by 240,183 shares, totaling 11,301,501 shares worth about $12.9 million. State Street Corp added 549,615 shares, raising its holdings to 9,501,377 shares valued at $10.8 million.
OPKO Health, Inc. Stock Down 3.4%
Shares of OPK traded near $1.43 on Tuesday. The company has seen varied interest from institutional investors, as indicated by recent filings. The stock's performance and institutional interest may be influenced by market conditions and company developments.
$OPK stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at OPKO Health, Inc.
In addition to Yu Alice Lin-Tsing, other insiders were active on June 18, 2026. Richard Pfenniger Jr. bought 60,000 shares, while John Paganelli, Uppaluri Subbarao, Roger Medel MD, and Prem Lachman each acquired 30,000 shares. These purchases were also not part of pre-planned trading programs.
Analysts Set New Price Targets
On March 2, 2026, Barrington Research maintained its buy rating on OPK with a price target of $1.50. Jefferies downgraded the stock to hold with a target of $1.60 on October 31, 2025. Overall, the consensus remains positive, with a majority of analysts recommending a buy.
Bottom Line
Insider buying at OPK, including Yu Alice Lin-Tsing's recent purchase, can be a sign of confidence. Institutional investors like BlackRock and Vanguard have also shown interest in the stock. Analysts largely maintain a buy rating, suggesting optimism about OPK's prospects. However, it's important to remember that 13F filings and insider transactions are backward-looking and may not reflect current positions.
Get OPKO Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $OPK, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.